Exploring Enrollment and Engagement Trends in Individuals Managing Keratoconus: A Comprehensive Examination of Data on Keratoconus Clinical Trials

Power Life Sciences Inc.1 site in 1 country500 target enrollmentMarch 2025

ConditionsKeratoconus

Overview

Phase: Not Applicable
Intervention: Not specified
Conditions: Keratoconus
Sponsor: Power Life Sciences Inc.
Enrollment: 500
Locations: 1
Primary Endpoint: Number of keratoconus patients who remain in clinical trial until completion
Status: Not yet recruiting
Last Updated: 2 years ago

Overview Investigators Eligibility Criteria Outcomes Sites Similar Trials

Overview

Brief Summary

This study aims to investigate the influences behind patient choices regarding involvement, discontinuation, or re-engagement in keratoconus clinical trials. Uncovering these factors is essential to enhance the relevance and efficacy of future research endeavors.

In essence, this trial aims to deepen understanding of the factors influencing participation in keratoconus clinical trials. Elevating participation rates could expedite the development of innovative treatments for this challenging condition.

Registry

clinicaltrials.gov

Start Date

March 2025

End Date

March 2027

Last Updated

2 years ago

Study Type

Observational

Sex

All

Investigators

Sponsor

Power Life Sciences Inc.

Responsible Party

Sponsor

Eligibility Criteria

Inclusion Criteria

•Signed Written Informed Consent
•Aged ≥ 18 years old
•No prior treatment for keratoconus

Exclusion Criteria

•Participant is actively receiving study therapy in another
•Inability to provide written informed consent
•Women of childbearing potential without a negative pregnancy test; or women who are lactating.